A detailed history of Traverso Chambers Private Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Traverso Chambers Private Wealth Management, LLC holds 683 shares of LLY stock, worth $551,720. This represents 0.1% of its overall portfolio holdings.

Number of Shares
683
Previous 705 3.12%
Holding current value
$551,720
Previous $378,000 5.29%
% of portfolio
0.1%
Previous 0.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 08, 2024

SELL
$525.19 - $619.13 $11,554 - $13,620
-22 Reduced 3.12%
683 $398,000
Q3 2023

Oct 26, 2023

BUY
$434.7 - $599.3 $11,302 - $15,581
26 Added 3.83%
705 $378,000
Q2 2022

Jul 13, 2022

BUY
$278.73 - $327.27 $189,257 - $222,216
679 New
679 $220,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $768B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Traverso Chambers Private Wealth Management, LLC Portfolio

Follow Traverso Chambers Private Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Traverso Chambers Private Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Traverso Chambers Private Wealth Management, LLC with notifications on news.